Claudia Lanari

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.

Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.

Journal: Oncotarget

Published: April 09, 2026

Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer.

Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer.

Journal: British journal of cancer

Published: October 03, 2025

Buenos Aires Breast Cancer Symposium 2024: bridging basic and clinical research in breast cancer.

Buenos Aires Breast Cancer Symposium 2024: bridging basic and clinical research in breast cancer.

Journal: Medicina

Published: June 27, 2025

Correction: Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.

Correction: Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.

Journal: Oncotarget

Published: May 20, 2025

Buenos Aires Breast Cancer Symposium (BA-BCS 2024) A Second Successful "Trial" for Bringing Together both World Hemispheres To Debate the Future of Translational Breast Cancer Research.

Buenos Aires Breast Cancer Symposium (BA-BCS 2024) A Second Successful "Trial" for Bringing Together both World Hemispheres To Debate the Future of Translational Breast Cancer Research.

Journal: Journal of mammary gland biology and neoplasia

Published: January 07, 2025

Deciphering the causes of advanced-stage disease at diagnosis among breast cancer patients who attended a suburban hospital in Buenos Aires.

Deciphering the causes of advanced-stage disease at diagnosis among breast cancer patients who attended a suburban hospital in Buenos Aires.

Journal: Medicina

Published: October 14, 2024

Steroid hormone receptors, exome sequencing and treatment responsiveness of breast cancer patient-derived xenografts originated in a South American country.

Steroid hormone receptors, exome sequencing and treatment responsiveness of breast cancer patient-derived xenografts originated in a South American country.

Journal: Scientific reports

Published: September 10, 2024

Higher risk of recurrence in early-stage breast cancer patients with increased levels of ribosomal protein S6.

Higher risk of recurrence in early-stage breast cancer patients with increased levels of ribosomal protein S6.

Journal: Scientific reports

Published: June 19, 2024

FGFR2-RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression.

FGFR2-RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression.

Journal: International journal of cancer

Published: March 18, 2024

Antiprogestins for breast cancer treatment: We are almost ready.

Antiprogestins for breast cancer treatment: We are almost ready.

Journal: The Journal of steroid biochemistry and molecular biology

Published: November 29, 2023

Tumor Lipid Signatures Are Descriptive of Acquisition of Therapy Resistance in an Endocrine-Related Breast Cancer Mouse Model.

Tumor Lipid Signatures Are Descriptive of Acquisition of Therapy Resistance in an Endocrine-Related Breast Cancer Mouse Model.

Journal: Journal of proteome research

Published: July 27, 2023

Steroid profile in patients with breast cancer and in mice treated with mifepristone.

Steroid profile in patients with breast cancer and in mice treated with mifepristone.

Journal: Endocrine-related cancer

Published: July 25, 2023

Showing 1-12 of 76

Last Updated: 09/26/2026